The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) - PubMed (original) (raw)
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)
Prakash G Jagtap et al. Bioorg Med Chem Lett. 2004.
Abstract
A series of novel 4-(N-acyl)-2,3-dihydro-1H-isoindol-1-ones have been prepared from methyl-3-nitro-2-methylbenzoate and linked through various spacers to the adenosine derivatives 11 and 12. We found that potent inhibition of poly(ADP-ribose)polymerase-1 (PARP-1) was achieved when isoindolinone was linked to adenosine by a spacer group of a specific length. Introduction of piperazine and succinyl linkers between the isoindolinone and adenosine core structures resulted in highly potent compounds 8a and 10b, which showed IC(50) values of 45 and 100 nM, respectively.
Similar articles
- Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.
Canan Koch SS, Thoresen LH, Tikhe JG, Maegley KA, Almassy RJ, Li J, Yu XH, Zook SE, Kumpf RA, Zhang C, Boritzki TJ, Mansour RN, Zhang KE, Ekker A, Calabrese CR, Curtin NJ, Kyle S, Thomas HD, Wang LZ, Calvert AH, Golding BT, Griffin RJ, Newell DR, Webber SE, Hostomsky Z. Canan Koch SS, et al. J Med Chem. 2002 Nov 7;45(23):4961-74. doi: 10.1021/jm020259n. J Med Chem. 2002. PMID: 12408707 - Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
Yao H, Ji M, Zhu Z, Zhou J, Cao R, Chen X, Xu B. Yao H, et al. Bioorg Med Chem. 2015 Feb 15;23(4):681-93. doi: 10.1016/j.bmc.2014.12.071. Epub 2015 Jan 8. Bioorg Med Chem. 2015. PMID: 25614115 - Synthesis and evaluation of tricyclic derivatives containing a non-aromatic amide as inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1).
Park CH, Chun K, Joe BY, Park JS, Kim YC, Choi JS, Ryu DK, Koh SH, Cho GW, Kim SH, Kim MH. Park CH, et al. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2250-3. doi: 10.1016/j.bmcl.2010.02.014. Epub 2010 Feb 8. Bioorg Med Chem Lett. 2010. PMID: 20189385 - Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy.
Heitz F, Harter P, Ewald-Riegler N, Papsdorf M, Kommoss S, du Bois A. Heitz F, et al. Expert Rev Anticancer Ther. 2010 Jul;10(7):1125-36. doi: 10.1586/era.10.53. Expert Rev Anticancer Ther. 2010. PMID: 20645701 Review. - Poly(ADP-ribose) polymerase activity and inhibition in cancer.
Dulaney C, Marcrom S, Stanley J, Yang ES. Dulaney C, et al. Semin Cell Dev Biol. 2017 Mar;63:144-153. doi: 10.1016/j.semcdb.2017.01.007. Epub 2017 Jan 10. Semin Cell Dev Biol. 2017. PMID: 28087320 Review.
Cited by
- Multicomponent reactions (MCRs): a useful access to the synthesis of benzo-fused γ-lactams.
de Marigorta EM, Santos JML, Ochoa de Retana AM, Vicario J, Palacios F. de Marigorta EM, et al. Beilstein J Org Chem. 2019 May 8;15:1065-1085. doi: 10.3762/bjoc.15.104. eCollection 2019. Beilstein J Org Chem. 2019. PMID: 31164944 Free PMC article. Review. - Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei.
Schlesinger M, Vilchez Larrea SC, Haikarainen T, Narwal M, Venkannagari H, Flawiá MM, Lehtiö L, Fernández Villamil SH. Schlesinger M, et al. Parasit Vectors. 2016 Mar 23;9:173. doi: 10.1186/s13071-016-1461-1. Parasit Vectors. 2016. PMID: 27007296 Free PMC article. - Regulated necrosis: disease relevance and therapeutic opportunities.
Conrad M, Angeli JP, Vandenabeele P, Stockwell BR. Conrad M, et al. Nat Rev Drug Discov. 2016 May;15(5):348-66. doi: 10.1038/nrd.2015.6. Epub 2016 Jan 18. Nat Rev Drug Discov. 2016. PMID: 26775689 Free PMC article. Review. - AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization.
Spiegel JO, Durrant JD. Spiegel JO, et al. J Cheminform. 2020 Apr 17;12(1):25. doi: 10.1186/s13321-020-00429-4. J Cheminform. 2020. PMID: 33431021 Free PMC article. - Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.
Curtin NJ, Szabo C. Curtin NJ, et al. Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29. Mol Aspects Med. 2013. PMID: 23370117 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous